Tocilizumab as Adjuvant Therapy in Refractory Antibody Mediated Rejection in Pediatric Kidney Transplant Recipients

ABSTRACT:

SUBMITTER: Durkan A 

PROVIDER: S-EPMC12322639 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature